Voloridge Investment Management
ASND icon

Voloridge Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Voloridge Investment Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.82M Sell
29,303
-84,972
-74% -$19.8M 0.03% 465
2026
Q1 		$26.1M Sell
114,275
-101,898
-47% -$22.8M 0.1% 279
2025
Q4 		$46.1M Sell
216,173
-18,224
-8% -$3.76M 0.16% 160
2025
Q3 		$46.6M Sell
234,397
-28,870
-11% -$5.38M 0.16% 156
2025
Q2 		$45.4M Sell
263,267
-82,751
-24% -$13.5M 0.17% 153
2025
Q1 		$53.9M Buy
346,018
+47,022
+16% +$6.72M 0.2% 142
2024
Q4 		$41.2M Sell
298,996
-98,017
-25% -$12.9M 0.15% 196
2024
Q3 		$59.3M Buy
397,013
+50,795
+15% +$6.86M 0.22% 122
2024
Q2 		$47.2M Buy
346,218
+38,719
+13% +$5.27M 0.18% 176
2024
Q1 		$46.5M Buy
307,499
+234,164
+319% +$33.4M 0.17% 173
2023
Q4 		$9.24M Buy
73,335
+53,427
+268% +$5.33M 0.04% 490
2023
Q3 		$1.86M Buy
+19,908
New +$1.86M 0.01% 940
2022
Q2 		– Sell
-1,887
Closed -$221K – 1418
2022
Q1 		$221K Sell
1,887
-2,772
-59% -$321K ﹤0.01% 1290
2021
Q4 		$627K Sell
4,659
-1,695
-27% -$252K ﹤0.01% 1372
2021
Q3 		$1.01M Buy
+6,354
New +$870K 0.01% 1281
2021
Q1 		– Sell
-5,618
Closed -$937K – 1376
2020
Q4 		$937K Sell
5,618
-1,439
-20% -$238K 0.01% 985
2020
Q3 		$1.09M Buy
7,057
+116
+2% +$16.7K 0.01% 915
2020
Q2 		$1.03M Buy
+6,941
New +$953K 0.01% 844
2020
Q1 		– Sell
-33,800
Closed -$4.7M – 1083
2019
Q4 		$4.7M Buy
33,800
+9,439
+39% +$1.05M 0.09% 284
2019
Q3 		$2.35M Buy
24,361
+22,291
+1,077% +$2.49M 0.04% 408
2019
Q2 		$238K Sell
2,070
-4,796
-70% -$574K 0.01% 679
2019
Q1 		$808K Buy
+6,866
New +$601K 0.02% 548

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Voloridge Investment Management's ASND Position: Q2 2026 in Review

Voloridge Investment Management reduced its Ascendis Pharma A/S (ASND) stake by 74% in Q2 2026, selling an estimated $19.8M and leaving 29,303 shares worth $7.82M. The position accounts for 0.03% of the portfolio, ranked #465.

Voloridge Investment Management first reported a position in ASND in Q1 2019 and has held it in 22 quarters since. The position peaked at $59.3M in Q3 2024. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Voloridge Investment Management held 29,303 shares of Ascendis Pharma A/S worth $7.82M as of Q2 2026.
  • Voloridge Investment Management sold 84,972 Ascendis Pharma A/S shares in Q2 2026, an estimated $19.8M.
  • Ascendis Pharma A/S made up 0.03% of Voloridge Investment Management's portfolio in Q2 2026, its #465 holding.
  • Voloridge Investment Management first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 22 quarters since.
  • Voloridge Investment Management's Ascendis Pharma A/S position peaked at $59.3M in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.